114 results on '"Schenk, Johanna"'
Search Results
2. Prenatal Diagnosis, Course and Outcome of Patients with Truncus Arteriosus Communis.
3. Associated Anomalies and Outcome in Patients with Prenatal Diagnosis of Aortic Arch Anomalies as Aberrant Right Subclavian Artery, Right Aortic Arch and Double Aortic Arch
4. Monitoring of Women with Anti-ro/La Antibodies in Germany – Status Quo and Intensified Monitoring Concepts
5. Natural history of pulmonary atresia with intact ventricular septum (PAIVS) and critical pulmonary stenosis (CPS) and prediction of outcome
6. Declaration of Helsinki: ethical norm in pursuit of common global goals.
7. Traditionsbezug und Transformation
8. Monitoring of Women with Anti-Ro/SSA and Anti-La/SSB Antibodies in Germany—Status Quo and Intensified Monitoring Concepts.
9. cfDNA mit Verdacht auf XXX bei einem weiblichen Feten mit zytogenetisch diagnostizierter Pentasomie X
10. Ebstein-Anomalie und Trikuspidalklappendysplasie-Spektrum, assoziierte Anomalien und Outcome bei pränataler Diagnose
11. Perinatal changes in myocardial function: Speckle Tracking Echocardiography reference values during the transition from fetal to postnatal life from a prospective longitudinal cohort
12. Der Bischof als Rhetor, oder: Wie reagiert man auf ‚rufschädigende Gerüchte‘?
13. Einleitung
14. Comparison of the Results of Prenatal and Postnatal Echocardiography and Postnatal Cardiac MRI in Children with a Congenital Heart Defect
15. Fluid Dynamics of the São Jorge Channel, Azores Plateau – First results of RV Meteor expedition M186
16. Multicenter clinical experience with non‐invasive cell‐free DNA screening for monosomy X and related X‐chromosome variants
17. Turner syndrome‐omphalocele association: Incidence, karyotype, phenotype and fetal outcome
18. Magmatic and geodynamic evolution of the King’s Trough Complex – The Grand Canyon of the North Atlantic
19. Analysis of the Results of Sonographic Screening Examinations According to the Maternity Guidelines Before and After the Introduction of the Extended Basic Screening (IIb Screening) in Hesse.
20. The Value of Delta Middle Cerebral Artery Peak Systolic Velocity for the Prediction of Twin Anemia-Polycythemia Sequence—Analysis of a Heterogenous Cohort of Monochorionic Twins
21. The Evolution and Developing Importance of Fetal Magnetic Resonance Imaging in the Diagnosis of Congenital Cardiac Anomalies: A Systematic Review
22. The continuation of clinical trials in times of war: A need to develop ethics and situationally adaptive clinical research guidelines
23. The ethical responsibility to continue investigational treatments of research participants in situation of armed conflicts, economic sanctions or natural catastrophes
24. Is Fetal Hydrops in Turner Syndrome a Risk Factor for the Development of Maternal Mirror Syndrome?
25. Is Fetal Hydrops in Turner Syndrome a Risk Factor for the Development of Maternal Mirror Syndrome?
26. Analysis of the Results of Sonographic Screening Examinations According to the Maternity Guidelines Before and After the Introduction of the Extended Basic Screening (IIb Screening) in Hesse
27. Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics
28. Shaping IFAPP’s Future: A Process to Help the International Federation of Associations of Pharmaceutical Physicians Evolve
29. Development and Use of Gene Therapy Orphan Drugs—Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society
30. Leading clinical projects: a survey of clinical research professionals asked: What makes you a successful project leader?
31. From Berlin to Cancun: message from the new president of IFAPP
32. Project leadership: getting it right: a review of the essential requirements for good project leaders and the crucial role they must play
33. Measures of success: paying attention to key performance metrics will eventually reduce global clinical development times and deliver innovative treatment earlier
34. Development and Use of Gene Therapy Orphan Drugs—Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society
35. Umbrosa lux. Obscuritas in der lateinischen Epistolographie der Spätantike Raphael Schwitter
36. Message from Dr Johanna Schenk, retiring President of IFAPP
37. Message from Dr Joanna Schenk, President of IFAAP
38. Letter from the President, Dr Johanna Schenk
39. IFAPP meeting on education in pharmaceutical medicine: Wednesday, 24 January 2001 14.00–18.00 h. Venue: Bristol Stephanie Hotel, Avenue Louise 91–93, 1050 Brussels
40. Message from the President: Being a global, virtual Federation
41. The Shared Ethical Responsibility of Medically and Non-medically Qualified Experts in Human Drug Development Teams
42. Gender-specific attitudes and competences of young professionals in the context of digitalization
43. Corrigendum: Core competencies for pharmaceutical physicians and drug development scientists
44. Gender-specific attitudes and competences of young professionals in the context of digitalization.
45. Core competencies for pharmaceutical physicians and drug development scientists
46. Project leadership: getting it right
47. Kardiologische Prävention — Welchen Beitrag kann ein pharmazeutisches Unternehmen leisten?
48. Digesting the directive
49. Leading Clinical Projects.
50. Shaping IFAPP's Future.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.